Hisamitsu Pharmaceutical Co (FRA:HPX) E10: €1.28 (As of Nov. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:HPX Hisamitsu Pharmaceutical Co Inc FRA:HPX
65 GF Score
Price €31.80
GF Value €25.90
View Full Analysis

What is Hisamitsu Pharmaceutical Co E10?

Hisamitsu Pharmaceutical Co FRA:HPX 65 E10 is €1.28 as of Nov. 2025. GuruFocus rates FRA:HPX with a GF Score™ of 65/100 and a GF Value™ of €25.90.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Hisamitsu Pharmaceutical Co's adjusted earnings per share data for the three months ended in Nov. 2025 was €0.383. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €1.28 for the trailing ten years ended in Nov. 2025.

During the past 12 months, Hisamitsu Pharmaceutical Co's average E10 Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Hisamitsu Pharmaceutical Co was 1.00% per year. The lowest was -3.90% per year. And the median was -2.40% per year.

As of today (2026-07-15), Hisamitsu Pharmaceutical Co's current stock price is €31.80. Hisamitsu Pharmaceutical Co's E10 for the quarter that ended in Nov. 2025 was €1.28. Hisamitsu Pharmaceutical Co's Shiller PE Ratio of today is 24.84.

During the past 13 years, the highest Shiller PE Ratio of Hisamitsu Pharmaceutical Co was 37.52. The lowest was 17.68. And the median was 22.68.


Hisamitsu Pharmaceutical Co  (FRA:HPX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hisamitsu Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=31.80/1.28
=24.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Hisamitsu Pharmaceutical Co was 37.52. The lowest was 17.68. And the median was 22.68.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Hisamitsu Pharmaceutical Co E10 Related Terms


Hisamitsu Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Hisamitsu Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co E10 Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.15 1.06 1.14 1.38 0.00

Hisamitsu Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 1.28 1.33 1.28 0.00

FRA:HPX vs ESPR, AMPH, ETON: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Shiller PE Ratio falls into.


FRA:HPX
65GF Score
Hisamitsu Pharmaceutical Co Inc FRA:HPX
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hisamitsu Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hisamitsu Pharmaceutical Co's adjusted earnings per share data for the three months ended in Nov. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Nov. 2025 (Change)*Current CPI (Nov. 2025)
=0.383/113.2000*113.2000
=0.383

Current CPI (Nov. 2025) = 113.2000.

Hisamitsu Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201602 0.230 97.800 0.266
201605 0.434 98.200 0.500
201608 0.493 97.900 0.570
201611 0.912 98.600 1.047
201702 0.208 98.100 0.240
201705 0.354 98.600 0.406
201708 0.526 98.500 0.604
201711 0.582 99.100 0.665
201802 0.294 99.500 0.334
201805 0.318 99.300 0.363
201808 0.532 99.800 0.603
201811 0.387 100.000 0.438
201902 0.564 99.700 0.640
201905 0.188 100.000 0.213
201908 0.577 100.000 0.653
201911 0.797 100.500 0.898
202002 0.335 100.300 0.378
202005 0.012 100.100 0.014
202008 0.349 100.100 0.395
202011 0.201 99.500 0.229
202102 0.339 99.800 0.385
202105 0.218 99.400 0.248
202108 0.250 99.700 0.284
202111 0.115 100.100 0.130
202202 0.327 100.700 0.368
202205 0.150 101.800 0.167
202208 0.445 102.700 0.490
202211 0.261 103.900 0.284
202302 0.200 104.000 0.218
202305 0.349 105.100 0.376
202308 0.356 105.900 0.381
202311 0.298 106.900 0.316
202402 0.155 106.900 0.164
202405 0.379 108.100 0.397
202408 0.364 109.100 0.378
202411 0.381 110.000 0.392
202502 0.699 110.800 0.714
202505 0.215 111.800 0.218
202508 0.360 112.100 0.364
202511 0.383 113.200 0.383

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €1.28 mean?
Hisamitsu Pharmaceutical Co (FRA:HPX) has a E10 of €1.28 as of Nov. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Hisamitsu Pharmaceutical Co and its competitors.
Is Hisamitsu Pharmaceutical Co's E10 too high?
Hisamitsu Pharmaceutical Co's current E10 is €1.28. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's E10 compare to ESPR and AMPH?
Hisamitsu Pharmaceutical Co's E10 of €1.28 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Hisamitsu Pharmaceutical Co and its competitors. Hisamitsu Pharmaceutical Co's current E10 is €1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Hisamitsu Pharmaceutical Co (FRA:HPX) has a current E10 of €1.28. The stock's GF Value™ is €25.90, compared to a current price of €31.80 — trading 22.8% above its estimated fair value. The current E10 is €1.28. Hisamitsu Pharmaceutical Co's overall GF Score™ is 65/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (FRA:HPX), the current E10 is €1.28 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hisamitsu Pharmaceutical Co (FRA:HPX) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of €31.80 is trading 22.8% above its estimated GF Value™ of €25.90.

Key valuation signals for FRA:HPX:

  • E10: €1.28
  • GF Value™: €25.90 vs. price of €31.80 (22.8% above fair value)
  • GF Score™: 65/100

No single metric tells the full story. See the FRA:HPX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hisamitsu Pharmaceutical Co Business Description

Other Exchanges HTSUY:USA
Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
65GF Score

Get the complete analysis for FRA:HPX

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€31.80
Price
€25.90
GF Value